Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/12/011004
CTRI/2017/12/011004
Not yet recruiting
Phase 2

An Open Label Clinical Study to Evaluate the Efficacy and Safety of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)â??

The Himalaya Drug Company0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
The Himalaya Drug Company
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Women with signs and symptoms of PCOS like irregular menstrual cycles, weight gain, biochemical/clinical hyperandrogenemia, hirsutism etc.
  • •2\. History of PCOS with \< 8 periods the preceding year.
  • •3\. PCOS confirmed by Clinical and/or biochemical and/or ultrasonographical findings.
  • •4\. Willingness to sign consent for study including participation with collection of blood specimens.

Exclusion Criteria

  • •1\. Patients who is not using oral contraceptive pills, hormonal treatment or IUCDs.
  • •2\. Patients who had no systemic illness like hypertension, renal disease, tuberculosis, hepatic disease, diabetes, coagulation disorder, etc.
  • •3\. Patients with organic lesion of the reproductive tract especially any benign or malignant growth, extensive cervical erosion, cervical polyps, endometriosis.
  • •4\. Patients with severe Hepatic/ cardiac/ mental illness.
  • •5\. Patients unwilling to provide informed consent or abide by the requirements of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study to Determine the Effect of Trucrose in Patients with Type II Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2020/07/026346Trulit Herbals
Not yet recruiting
Phase 3
A CLINICAL STUDY TO KNOW THE EFFECT OF AN AYURVEDIC FORMULATION (GUDA-HARITAKI WITH GUDUCHI KASHAYAM) FOR THE TREATMENT OF VATA RAKTA, GOUTY ARTHRITIS.Health Condition 1: M100- Idiopathic gout
CTRI/2022/09/045834Jammu Institute of Ayurveda and Research Jammu
Recruiting
Not Applicable
Abnormal Uterine Bleeding ManagementHealth Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
CTRI/2021/12/038921Magnet Labs under Mankind Pharma
Completed
Phase 4
A clinical study to evaluate the efficacy and safety of URAL tablet
CTRI/2023/04/051931Vasu Research Centre
Not yet recruiting
Phase 2
A Study to Evaluate The Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.Health Condition 1: E784- Other hyperlipidemia
CTRI/2021/07/034572Sane Guruji Arogya Kendra